Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
IGC Pharma, Inc. (IGC) had Cost of Goods Sold of $0.17M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.33M |
|
$-1.60M |
|
|
Cost of Goods Sold |
$0.17M |
$0.15M |
|
$2.23M |
|
$-1.91M |
|
$0.31M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.91M |
|
$-1.76M |
|
83.03M |
|
83.03M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$2.15M |
|
$3.10M |
|
$5.79M |
|
$7.94M |
|
$1.73M |
|
$0.13M |
|
$0.14M |
|
$1.86M |
|
$6.08M |
|
$4.08M |
|
$6.08M |
|
84.14M |
|
| Cash Flow Statement Financials | |
$-1.41M |
|
$0.58M |
|
$0.85M |
|
$0.41M |
|
$0.45M |
|
$0.05M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
46.95% |
|
-580.79% |
|
-580.79% |
|
-- |
|
-487.50% |
|
-487.50% |
|
$-0.71M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.13 |
|
3.77 |
|
23.87 |
|
-26.31% |
|
-39.18% |
|
-20.13% |
|
-25.74% |
|
$0.07 |
|
$-0.01 |
|
$-0.02 |
|